In his thirty-eight years as a venture capitalist, Mr. Lefkoff has invested in 62 Colorado companies.
Mr. Lefkoff founded Array BioPharma in May 1998 with Marv Caruthers and a group of Amgen scientists. Mr. Lefkoff was the Chairman of the Board of Array from its inception through August 2018, when Array’s targeted therapy for melanoma was approved by the FDA. In July 2019, Array was acquired by Pfizer for $11.8 billion in cash, the largest acquisition of a venture-backed life sciences company in the history of Colorado.
Mr. Lefkoff founded Array BioPharma in May 1998 with Marv Caruthers and a group of Amgen scientists. Mr. Lefkoff was the Chairman of the Board of Array from its inception through August 2018, when Array’s targeted therapy for melanoma was approved by the FDA. In July 2019, Array was acquired by Pfizer for $11.8 billion in cash, the largest acquisition of a venture-backed life sciences company in the history of Colorado.
Location
Boulder, Colorado
Notable investments
No items found.
Check size range(s)
$1M - $3M
$3M - $10M
Rounds their fund invests in
Series A
Series B+
Rounds their fund leads
Series A
Sectors their fund invests in
Biotech
Enterprise
Geographies their fund invests in
USA
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
Boulder Ventures
About the Fund
Invests in high-potential Information Technology and Biotechnology companies located at the Colorado Front Range and the Mid-Atlantic region
View Profile
Their Colleagues
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets
